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Abstract In common with most other matrix metallopro- 
teinases, gelatinase A has a non-catalytic C-terminal domain that 
displays sequence homology to haemopexin. Crystals of this do- 
main were used by molecular eplacement to solve its molecular 
structure at 2.6 A resolution, which was refined to an R value of 
17.9%. This structure has a discqike shape, with the chain folded 
into a/3-propeller structure that has pseudo four-fold symmetry. 
Although the topology and the side-chain arrangement are very 
similar to the equivalent domain of fibroblast collagenase, signif- 
icant differences in surface charge and contouring are observable 
on 1 side of the gelatinase A disc. This difference might be a factor 
in allowing the gelatinase A C-terminal domain to bind to natural 
inhibitor TIMP-2. 
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I. Introduction 
The matrix metalloproteinases (MMPs) are a family of zinc- 
dependent endopeptidases that degrade components of the ex- 
tracellular matrix [1]. Although required for normal develop- 
ment and maintenance, their activity has also been linked to the 
uncontrolled tissue destruction that accompanies many pa- 
thological conditions [2]. Gelatinase A (MMP2; EC 3.4.24.24, 
72-kDa gelatinase, type-IV collagenase) is secreted by several 
cell types as the latent precursor, progelatinase A (proMMP2), 
and has recently been implicated in promoting tumour cell 
invasion [3], a role, which might be facilitated by its ability to 
bind to and be activated by constituents of the cell surface [4 -8]. 
The primary sequence of the MMPs can be divided into 
functionally defined domains: the N-terminal propeptide lost 
upon activation, and the catalytic domain joined via a hinge 
region to a haemopexin-like C-terminal domain (CTD) pos- 
sessed by all the MMPs except matrilysin (MMP7), The CTD 
of the collagenases (MMPsl  and 8) binds the enzymes to the 
collagens of types I - I I I  [9,10], thereby positioning the substrate 
for cleavage at the active site [1 l]. MMP2 and the closely related 
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gelatinase B (MMP9) also bind collagen but do so using 
3 fibronectin-related type-II modules, which are inserted into 
their catalytic domains [12-16]. They efficiently degrade native 
type-IV and -V collagens, all denatured collagens, elastin, and 
fibronectin [12,13,17,18]; none of these activities is lost upon 
removal of the CTD [4] (G. Murphy, unpubl, results). The 
MMP2-CTD is required, however, for 3 particular properties 
of proMMP2: cell surface binding, activation [4~6], and binding 
of the proenzyme to the natural inhibitor TIMP-2 [5,19]. In- 
deed, the recent isolation of ternary complexes of proMMP2, 
TIMP-2, and MT-MMP (a membrane-bound MMP that acti- 
vates proMMP2 [20]) suggests that the binding of TIMP-2 is 
of central importance to MMP2 function [21]. CTD interac- 
tions also assist in the inhibition of active MMP2 by TIMPs 1 
and 2 [22]. 
In this report, the crystal structure of the MMP2-CTD is 
described. By comparing it to the recently obtained structure 
of the MMP-1 CTD [23], we make predictions concerning pos- 
sible sites of interaction for TIMP-2. 
2. Materials and methods 
The active-site mutant Glu-375-Ala of human proMMP2 was over- 
expressed in mouse myeloma cells and isolated as previously described 
[19]. For crystallization, the sample was dialyzed in the absence of 
inhibitor against 4mM MES, pH 7.5, 10 mM CaCIz, 0.1 M NaCI, 0.02% 
w/v NaN> After adjusting the sample to 0.15 M citrate pH 6 and 2.5% 
PEG 6000 (Serva, Heidelberg, Germany), it was equilibrated against 
0.9 M citrate at 20°C by hanging drop vapour diffusion. After about 
2 months, small plate-shaped crystals appeared, which diffracted X- 
rays to 2.5 ,~ resolution. These crystals were of orthorhombic space 
group P2~2j2~ and had the cell constants a = 55.78 A, b = 58.85 A and 
c = 93.14 A. Examination of these crystals by SDS-PAGE and N- 
terminal sequencing revealed that the crystallized protein comprises the 
CTD of MMP2, extending from Ile-451 to Cys-660 (using the nomen- 
clature of preMMP2 [12]). 
X-ray intensity data were recorded on an imaging plate detector 
(MAR Research, Hamburg, Germany), using graphite monochroma- 
tized CuKc~ radiation. Data were processed using the MOSFLM v5.23 
program package [24] and routines from the CCP4 suite [25]. The data 
collection statistics are summarized in Table 1. 
The structure was solved by Patterson search methods using the 
coordinates of the CTD of full-length porcine MMP1 [23] kindly pro- 
vided by Dr. R Brick and colleagues as a search model. The search 
model comprised residues Cys-278 to Cys-466 of porcine MMPI with 
all non-identical residues replaced by alanines. The rotational and 
translational search carried out with AMoRe [26] gave the highest 
solution with a correlation coefficient of 35.4 and an R factor of 56.2% 
(C = 25.8 and R = 58.8% for the second highest solution) in the resolu- 
tion range 12.0--3.0 A. A rigid-body refinement with AMoRe increased 
the correlation coefficient to 53.3 (R = 51.8%). 
All subsequent refinement s eps were performed with X-PLOR [27]. 
The rigid-body refinement was repeated, allowing an independent 
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movement ofeach of the 4 internal repeats of the CTD. After expansion 
of the resolution range to 12.0 2.6 A and positional refinement, most 
of the new side-chains could unambigiously be built into the electron 
density map using the interactive graphics program FRODO [28]. Only 
at the amino acid insertion sites of MMP2-CTD, the electron density 
remained poorly defined. After several cycles of building and refine- 
ment against omit maps, a simulated annealing calculation was carried 
out [29], which improved the map. Two sodium ions, which were later 
replaced by calcium ions, a chloride and 78 water molecules were 
added. The B factors were refined individually, with restraints on 
bonded and angle-related atoms. The R factor of the final model is 
17.9%, including data from 8 to 2.6 A resolution; the rms deviations 
from standard values of bond length and angles [30] are 0.011 ~, and 
1.67 °, respectively. 
The first 7 residues of the protein, from I1e-451 to Pro-457, are fully 
disordered. The chain is defined by electron density from Thr-458 
onwards. The main chain can be almost unambiguously traced down 
to the C-terminal Cys-660; only residues Thr-498 to Asp-501 are located 
in very weak density. Except for this site, only 2 peptide bonds, at 
Ile-468-Cys-469 and Ser-544-Ala-545, have bad difference densities; 
rebuilding leads to conformations with disallowed Ramachandran a - 
gles, however. The main chain angles of Asp-490 and Ala-545 are in 
'generously allowed' regions. The program PROCHECK [31] incorpo- 
rated in the CCP4 package indicates a favourable stereochemistry for
all other non-Gly and non-Pro residues. Of the 17 Pro residues con- 
tained in the crystallized fragment, 2 (Pro-457 and Pro-499) are not 
properly defined, 3 (Pro-506, Pro-553 and Pro-603) are cis-prolines, 
while the remaining 12 have trans-conformation. 
3. Results 
Similar to the CTDs of porcine MMP2 [23] and of rabbit 
haemopexin [32], the CTD of MMP2 exhibits the shape of a flat 
cylindrical disc, with an approximate height and diameter of 25 
and 40 /~, respectively. The polypeptide chain is essentially 
organized in 4 fl-sheets I-IV, which are arranged almost sym- 
metrically around a central axis giving rise to the formation of 
a 4-blade propeller (Fig. 1). Sheets I - IV are arranged in consec- 
utive order around the central axis. Each sheet is made up of 
4 antiparallel f -strands connected with a W-like strand topol- 
ogy. Each is strongly twisted, with the edge strands crossing 
over one another at an angle of about 60 ° . 
The first, innermost strands in all 4 sheets enter the propeller 
at a common side (its 'entrance side') and run almost parallel 
to one another along the propeller axis forming a central tun- 
nel, which opens slightly towards the other ('exit') side. Strands 
1 and 2 are connected by short fl-hairpin loops of 2 (sheet I) 
III 
Fig. 1. Ribbon diagram (stereoview) ofMMP2-CTD, shown against the 
exit side (see text). The domain is slightly tilted with respect o the 
pseudo four-fold symmetry axis of the fl-propeller structure to clarify 
the tracing of the N-terminal extension peptide and the position of the 
ions in the central channel. The 4 propeller blades are numbered and 
the order of the ions is calcium (light grey), chloride (dark grey) and 
calcium (light grey). The disulphide bond is shown in CPK-fashion 
clamping the C-terminus to blade I (figure generated using the program 
MOLSCRIPT [35].) 
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Fig. 2. Superposition (stereoview) of the Ca-chains of MMP2-CTD 
(thick line) and porcine MMP1 (thin line). The orientation of the do- 
mains is as in Fig. 1. The residues of MMP2-CTD are numbered at 
approximately 10-residue intervals (figure generated with 
MOLSCRIPT [35]). 
to 4 residues (sheets II- IV), which are arranged around the 
more open exit of the tunnel, while the 1,4 tight turns connect- 
ing strands 2 and 3 form the entrance to the tunnel together 
with the entering segments. The 3--44 loop of blade A compris- 
ing 8 residues is quite open and partially flexible, whereas the 
corresponding loops in the other 3 blades are compact. The 4th 
strands of blades II and III are interrupted by characteristic 
fl-bulges, which each are preceding a cis-Pro residue. The fl- 
bulge and cis-Pro together form a structural insertion unit, 
which allows the accommodation of 3 extra residues in strand 
4 (compared with sheet IV) without major sheet distortions (see 
Fig. 4). Both Pro residues are quite strongly conserved in the 
MMPs. Pro-506, likewise arranged in a c/s-conformation, occu- 
pies an equivalent MMP2-CTD site in blade I. This Pro residue 
seems to be confined to both gelatinases, but is lacking in all 
other MMPs. 
In all 4 blades, the outer strands loop around the periphery 
of the disc and end up in short 3,~ (blades I and II) or c~-helices 
(| I I  and IV). The chain then turns towards the tunnel entrance 
to begin the first strand of the next blade. At the end of the 
a-helix terminating blade IV, the C-terminus is tethered to the 
entering strand of blade I via disulfide bridge 469 660. This 
clamping of the N and the C-terminus is obviously important 
for the integrity of the CTDs [10]. 
A quantitative comparison with the CTD of porcine MMP1 
shows that the MMP2-CTD chain topology is quite similar and 
their secondary structure arrangement is virtually identical 
(Fig. 2). After optimal superposition of both domains, 171 
Ca-atom pairs of topologically equivalent residues differ less 
than 3 A, exhibiting an rms deviation of 1.22 ,~. The corre- 
sponding sequence alignment based on this superposition is 
shown in Fig. 3.66 topologically equivalent residues out of the 
192 residues contained in MMP2-CTD,  i.e. 35%, turn out to be 
identical. In general, the 4 sheets superimpose well, with only 
a slight increase in deviation towards the periphery (see Fig. 2). 
Larger deviations are only found in some of the fl-hairpin 
loops. Most noteworthy is the differing chain course in the large 
3--~ 4 loop of blade I, where the MMP2-CTD chain is partially 
undefined. Smaller, but significant deviations occur in the 1 --)2 
loops of blades II-1V (two residue insertion in MMP2), and in 
the 3--)4 loop of blade III. All of these differing loops are 
located on the exit side of the disc. 
The internal (pseudo) four-fold symmetry of the 
haemopexin-like domain is reflected to a high degree in the 
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Fig. 3. Amino acid sequence alignment of MMP2-CTD and porcine MMP1. Sequence data were taken from the PIR database. Alignment isbased 
on comparison of the spatial structures (this work, [23]). The N-terminal extension as well as the 4 domains of the fl-propeller structure are shown, 
with the secondary structure lements indicated for MMP2-CTD according to the definition of Kabsch and Sander [37]. Arrows represent fl-strands, 
cylinders a-helices. Structurally equivalent regions are shaded (light grey). The cysteines of the disulphide bond as well as the Ca2+-binding aspartates 
are boxed in dark grey (figure generated using the program ALSCRIPT [38]). 
similar scaffold architecture of the 4 blades (Fig. 4). This simi- 
larity is particularly strong between blades II-IV, where the 
Ca-atoms of the approximately 30 residues involved in fl-sheet 
formation exhibit rms deviations of 0.8~).95/~. Blade I differs 
most, mainly due to its larger 3--~4 loop and its more deviating 
4th strand. Alignment of the 4 chain segments forming blades 
I IV, done according to the topological equivalence, shows a 
15-30% identity within the sheet segments, again with blade I 
ranking lowest; the degree of residue similarity is considerably 
larger, however (see Fig. 3). 
The CTD disc is evenly filled with protein atoms, in spite of 
its volume, which has a strong radial increase. This is mainly 
achieved by an increase in the size of the contributing amino 
acids when going from the centre to the periphery. The internal 
strands are characterized by a preponderance of Ala residues, 
while strands 2 and 3 preferentially harbour large mainly aro- 
matic residues, such as Phe and Trp. The hydrophobic side- 
chains projecting from each sheet in an alternating manner 
combine with the corresponding side-chains of adjacent blades 
to form large hydrophobic lusters at the blade interfaces, 
Many of the contributing (aromatic) residues are identical or 
similar between the CTDs of MMP2 and porcine MMP1, and 
most of them are highly conserved in all MMPs. Towards the 
radial periphery, these hydrophobic regions are largely covered 
by the connecting helical fragments, which are anchored in 
these clusters via hydrophobic side-chains. Towards the exit 
side, these hydrophobic lusters are partially exposed to the 
bulk solvent. 
A prominent feature of the MMP2-CTD is the tunnel trav- 
ersing the centre of the disc (see Fig. 1). It is formed by the 4 
inner strands, which run parallel and are arranged in register. 
Due to a slight curvature in these strands, this tunnel opens 
Table 1 
Statistics for data collection and refinement 
Data collection 
Dataset NATI 
Maximal resolution 2.6 A 
Reflections measured 34708 
Unique reflections (I > 4o'(1)) 9618 
Rmerge ~ 0.069 (~-2.60 A) 
0.274 (2.65-2.60 A) 
Completeness 96.7% (00-2.60 A) 
71.3% (2.65 2.60/~) 
Refinement 
Resolution 8.0-2.6 A 
Reflections 8574 
R factor b 17.9% 
Total number of non-hydrogen atoms 1645 
Number of active non-hydrogen atoms 1603 
Number of waters 73 
Ions 3 
Geometry rms deviations 
Bond distances 0.011 A 
Angles 1.67 °
Mean B factor 19.1 A 2 
a Rmerge = ~,hZi l ) I  (h,i)-(I(h))l/Y~hY.~ I(h,i). 
bR factor = (YlFo-Fcl)/YFo × 100. 
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4. Discussion 
c 
Fig. 4. Superposition fthe Ca-chains of the 4 blades of MMP2-CTD 
(stereoview). Orientation isas of blade I in Fig. 1. The range of each 
blade is taken as in the sequence alignment (Fig. 3). The 4 blades are 
drawn with decreasing line thickness, with blade I having the thickest 
and blade IV the thinnest line (superposition was calculated with 
LSQMAN [36]; figure generated with MOLSCRIPT [35]). 
somewhat towards the exit side. Within this tunnel, 4 ions/ 
solvent molecules are found arranged along the pseudo four- 
fold axis, which tentatively have been assigned as 2 Ca 2÷ ions, 
a CI- ion and a water molecule (Fig. 5), based on their scatter- 
ing power and coordination geometry. The crystallization and 
the harvesting buffer contained high amounts of Ca 2+ and CI-, 
besides Na ÷ and citrate. The first of the Ca 2÷ ions, KA5, is 
positioned at the entrance to the tunnel, where it is tetragonally 
surrounded by the first carbonyl groups of each inner strand, 
donated by Asp-476, Asp-521, Asp-569 and Asp-618. The 
Ca2+-oxygen distances are 2,4-2.5 A, i.e. only slightly exceed 
mean values of Ca2+-carbonyl interactions in protein structures 
(2.36 A [33]). The B value of this Ca 2+ refines to 15 A 2, compa- 
rable to that of the coordinating carbonyl oxygens. A water 
molecule (W28), localized just outside of the tunnel entrance at 
a distance of 2.9 A, slightly away from the tunnel axis, forms 
the 5th Ca 2÷ ligand and occupies the vertex of a distorted 
tetragonal pyramid. Such a Ca 2+ coordination by only 5 oxygen 
ligands is not frequently observed, but might be forced here by 
the special tunnel environment. I  is noteworthy that the side- 
chains of the 4 Asp residues contributing the carbonyl ligands 
are neither direct Ca 2÷ ligands nor connected to it via the 
localized water ligand, due to structural restraints imposed 
from the main chain. An equivalent calcium ion with identical 
binding geometry has been observed in the porcine MMPI 
structure [23] and in the haemopexin domain [32]. 
The centre of the tunnel harbours an anion-cation couple 
(Fig. 5), which has been modeled as a CF Ca 2÷ pair (a Na + such 
as assumed in the haemopexin structure [32] would have unusu- 
ally low B values). The Ca 2+ (KA2, B = 20 A 2) is octahedrally 
surrounded by 6 ligands, with the 4 carbonyl oxygens of I1e-478, 
Val-533, Ala-571 and Val-620 placed at the corners of the 
central tetragonal plane. The C1- ion and a solvent molecule 
(W33) occupy the vertices in the tunnel centre and its exit, 
respectively (Fig. 5). The distances from the central Ca 2÷ ion 
to the 4 carbonyl oxygens are 2.6-2.7 ~, while 2.4 and 3.1 A 
to the water and the CI-, respectively. Another more distant 
water molecule is positioned towards the tunnel exit, but away 
from its axis. The C1- ion (B = 31 A 2) is tetragonally sur- 
rounded by the amide nitrogens of the same 4 residues, which 
also provide the KA2 carbonyl ligands. In agreement with the 
relatively large ionic radius of C1- (1.94 A [34]), the CV-nitro- 
gen distances are 3.8~,.0 A. In the porcine MMP1 structure, 
2 spheres of isolate density in the centre of the tunnel were 
interpreted as water molecules, however, with quite unusual 
ligand interactions. In the haemopexin structure, a similar elec- 
tron density was believed to account for a CI--Na + couple, with 
an additional phosphate anion bound to the sodium. 
The overall number of positively (26) and negatively charged 
residues (25) in MMP2-CTD is almost equal, their distribution 
over the molecular surface is, however, not uniform. In general, 
the acidic residues are preferentially clustered at both flat sides 
of the disc-like molecule, whereas the basic residues are pre- 
dominantly found at the radial periphery. In particular the 
entry side is characterized by a negative lectrostatic potential. 
Most of all, the 4 uncompensated Asp residues arranged 
around the tunnel entrance contribute to this potential and 
could provide strong anchoring points for approaching ligands 
of opposite charge. On the exit side, a surface patch of posi- 
tively charged residues centered around Lys-595, Lys-596 and 
Lys-597 is noteworthy, and extends from the tunnel exit along 
the surface of blade III towards the periphery. Most of the 
underlying basic residues are also found in other MMPs. Only 
Lys-597 and Arg-550, the latter situated on the exposing fl- 
bulge of blade H, are truly specific to MMP2. 
The initial (structurally defined) part of the linker peptide 
projects 5 residues in the axial direction out of the periphery 
of blade I (see Fig. 1). It exhibits an almost extended conforma- 
tion, which is supported only by a few weak intermolecular 
contacts with a symmetry-related molecule. From Pro-463 to 
Cys-469, this linker is in direct contact with the own CTD 
nestling against he 4th strand of blade I. A comparison with 
the full-length chain of the porcine MMP1 molecule (Fig. 2) 
shows that the course of this linker is quite similar from Pro-463 
onwards. Due to a slight kink at this Pro residue, the preceding 
fragments deviate slightly from one another, with both frag- 
ments exhibiting extended conformations. 
33 
Structural analysis of the MMP2-CTD reveals that it is to- 
pologically quite similar to that of porcine MMP1. The only 
significant conformational differences occur at the exit side of 
the disc, although both entry and exit sides display different 
charge patterns. The overall similarity is in agreement with the 
Fig. 5. Section through the refined MMP2-CTD structure along the 
tunnel axis, superimposed with the final electron density contoured at 
1 a (stereoview). Shown are the first 3 strands of blades I and III, 
respectively, together with the ions and solvent molecules arranged 
along the tunnel axis (figure generated with FRODO [28]. 
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close sequence homology that exists between these 2 MMPs 
(Fig. 3), and might be enforced by the many constraints that 
exist in this fl-propeller structure. 
The CTD of porcine MMP1 is connected to the catalytic 
domain by a short bulged segment and an extended linker 
peptide [23], which our structure suggests is a general feature 
of the MMPs. It is proposed that the MMP1 linker peptide acts 
as a fitting spacer that allows the entry side of the CTD to fold 
over the catalytic domain, thereby trapping bound triple helical 
collagen substrate at the active site cleft [11]. 
MMP2 does not use the CTD to bind collagen [15], but its 
linker peptide may instead be involved in correctly positioning 
bound TIMP-2. This is of importance to the inhibition of the 
active enzyme, because the interaction of the CTDs of TIMP-2 
and MMP2 allows the N-terminal domain of TIMP-2 effi- 
ciently to dock with the enzyme's active site [22]. Sequence 
comparison of the TIMPs revealed that TIMP-2 possesses a
negatively charged 'tail'. Removal of this tail decreased the 
association rate constant of TIMP-2 and active MMP2 and 
prevented the inhibitor from binding to proMMP2 [22]. It is 
possible, therefore, that the positively charged region located 
on the exit side and the periphery of blade III of the MMP2- 
CTD represents an anchoring site for TIMP-2. This is specula- 
tive and must be tested by generating mutants, in which the 
internal structure is unaltered. The MMP2-CTD structure de- 
scribed in this report provides a good foundation for the design 
of such experiments. 
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